Oct 6, 2026 08:01AM
Oct 6, 2026 08:00AM
Aug 18, 2026 07:00AM
Aug 18, 2026 07:00AM
Aug 6, 2026 07:00AM
Jun 25, 2026 07:40AM
Jun 23, 2026 07:00AM Amylyx ALS drug shows no serious adverse events in Phase 1 trial
Jun 23, 2026 07:00AM
Jun 8, 2026 09:00AM
May 15, 2026 12:12PM
May 15, 2026 12:11PM
May 7, 2026 07:00AM
May 5, 2026 07:01AM
May 5, 2026 07:00AM Amylyx Pharmaceuticals Announces U.S. Expanded Access Program for Adults with Post-Bariatric Hypoglycemia
Mar 25, 2026 06:57AM
Mar 24, 2026 07:00AM
Mar 24, 2026 07:00AM
Mar 3, 2026 07:00AM
Dec 19, 2025 09:06AM
Dec 5, 2025 09:00AM
Dec 5, 2025 09:00AM Amylyx Pharmaceuticals Announces New Safety and Tolerability Cohort 1 Data of AMX0114 in ALS from First-in-Human LUMINA Trial
Nov 6, 2025 07:00AM
Oct 20, 2025 07:49AM
Oct 8, 2025 08:44AM
Aug 27, 2025 07:05AM
Aug 27, 2025 07:00AM
Aug 7, 2025 07:00AM
Jul 14, 2025 03:41PM TD Cowen on Amylyx Pharmaceuticals inc. (AMLX): 'continue to see AMLX as undervalued for the potential of avexitide alone'
Jul 13, 2025 05:00PM
Jul 8, 2025 07:00AM
Jun 17, 2025 05:17AM
Jun 3, 2025 07:01AM
Jun 3, 2025 07:00AM
May 12, 2025 07:01AM
May 12, 2025 07:00AM Amylyx Pharmaceuticals Announces Positive Long-Term Results from Phase 2 HELIOS Clinical Trial of AMX0035 in People with Wolfram Syndrome
May 8, 2025 07:00AM
Apr 30, 2025 07:03AM
Apr 30, 2025 07:00AM
Mar 4, 2025 06:00AM
Jan 21, 2025 09:00AM
Jan 21, 2025 09:00AM
Jan 6, 2025 09:00AM Amylyx Pharmaceuticals Appoints Dan Monahan as Chief Commercial Officer
Dec 4, 2024 07:32AM
Dec 4, 2024 07:30AM
Nov 21, 2024 05:09AM
Nov 7, 2024 07:00AM
Oct 18, 2024 06:44AM
Oct 18, 2024 05:46AM
Oct 17, 2024 09:01AM Amylyx Pharmaceuticals (AMLX) Announces Positive Topline Results from Phase 2 HELIOS Clinical Trial Demonstrating Sustained Improvements with AMX0035 in People Living with Wolfram Syndrome
Oct 17, 2024 09:00AM

334,271 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All